Formats
  1. Journal Article (66975)
  2. Meeting Abstract (33621)
  3. Book Section (5116)
  4. Review (3781)
  5. Editorial (2185)
  6. Conference Paper (1531)
  7. Correspondence (669)
  8. Guidelines (666)
  9. Research Letter (554)
  10. Book Whole (345)
  11. Miscellaneous (340)
Groups
  1. Department of Medicine (39123)
  2. GSK Faculty (22500)
  3. Solid Tumor Oncology Division (22113)
  4. Surgery (21304)
  5. Survivorship Research (15795)
  6. Sloan Kettering Institute Faculty (15665)

More Groups

People
  1. Marc Ladanyi (1328)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1053)

More People

Years
  1. 2026 (1)
  2. 2025 (2315)
  3. 2024 (5382)
  4. 2023 (5808)
  5. 2022 (6169)
  6. 2021 (5720)

More Years

Publications
  1. Journal of Clinical Oncology (8596)
  2. Blood (4954)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2614)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1814)

More Publications

Publishers
  1. Elsevier Inc. (13867)
  2. American Society of Clinical Oncology (9180)
  3. Springer (7199)
  4. Nature Publishing Group (6392)
  5. American Association for Cancer Research (6014)
  6. Elsevier Science, Inc. (5526)

More Publishers

Results (115783)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • IMPACT: Immunotherapy in patients with metastatic cancers and CDK12 mutations
    Meeting Abstract

    Reimers, M. A.; Abida, W.; Chou, J.; George, D. J.; Heath, E. I.; McKay, R. R.; Pachynski, R. K.; Zhang, J.; Choi, J. E.; Feng, F. Y.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase III, randomized, open label, multicenter, global study of efficacy and safety of durvalumab in combination with gemcitabine plus cisplatin (G plus C) for neoadjuvant treatment followed by durvalumab alone for adjuvant treatment in muscle-invasive bladder cancer (MIBC) (NIAGARA)
    Meeting Abstract

    Powles, T.; Meeks, J. J.; Galsky, M. D.; Van der Heijden, M. S.; Nishiyama, H.; Al-Ahmadie, H.; Gupta, A. K.; Ye, J.; Donegan, S. E.; Ghiorghiu, D. C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Real-world assessment of practice efficiency with the introduction of subcutaneous rituximab
    Meeting Abstract

    Qiu, A.; Shapouri, S.; Drill, E. N.; Schade, J.; Ravelo, A.; Ni, A.; To, T. M.; Dawson, K. L.; Matasar, M. J.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Efficacy and safety of pembrolizumab in patients with advanced adrenocortical carcinoma
    Meeting Abstract

    Raj, N. P.; Zheng, Y.; Kelly, V.; Katz, S.; Chou, J. F.; Do, R. K. G.; Capanu, M.; Zamarin, D.; Ariyan, C. E.; Untch, B. R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Identification of a gene expression signature predictive of clinical benefit in patients with advanced mucosal melanoma (MCM) treated with immune checkpoint blockade
    Meeting Abstract

    Rapisuwon, S.; Shoushtari, A. N.; Gottesdiener, L. S.; Johnson, D. B.; Wang, D. Y.; Graham, G. T.; Goerlitz, D.; Berry, D.; Atkins, M. B.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • An open label phase 1/2A study to evaluate the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of TRC253, an androgen receptor antagonist, in patients with metastatic castration resistant prostate cancer
    Meeting Abstract

    Rathkopf, D. E.; Saleh, M. N.; Tsai, F. Y. C.; Bilen, M. A.; Rosen, L. S.; Gottardis, M.; Infante, J. R.; Adams, B. J.; Liu, L.; Theuer, C. P.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • The clinical utility of strict laboratory monitoring of CDK 4/6 inhibitors in metastatic breast cancer patients
    Meeting Abstract

    Patel, U.; Meisel, J. L.; Barbee, M. S.; Frinzi, K.; Sakach, E.; Chen, Z.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Inferior survival after microbiota injury: A multicenter alto-HCT study
    Meeting Abstract

    Peled, J. U.; Gomes, A. L. C.; Devlin, S. M.; Littmann, E. R.; Taur, Y.; Sung, A. D.; Weber, D.; Hashimoto, D.; Wright, R. J.; Amoretti, L.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult ALL
    Meeting Abstract

    Perica, K.; Flynn, J.; Curran, K. J.; Wang, X.; Halton, E.; Diamonte, C.; Pineda, J.; Bernal, Y.; Gonen, M.; Riviere, I.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Persistent radiation-induced alopecia in patients with central nervous system tumors and head and neck sarcomas
    Meeting Abstract

    Phillips, G. S.; Novetsky Friedman, D.; Trelles, S.; Kukoyi, O.; Freret, M.; Freites Martinez, A. D.; Unger, R. H.; Disa, J. J.; Wexler, L. H.; Beal, K.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save